Jinlei Liu

Jinlei Liu

Auto-generated profile, based on publicly available information

Jinlei Liu

Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
WDWenchao Dan
Wenchao Dan
JLJinlei Liu
Jinlei Liu
XGXinyuan Guo
Xinyuan Guo
BZBoran Zhang
Boran Zhang
YQYi Qu
Yi Qu
QHQingyong He
Qingyong He
Background and Aim. Antineoplastic drug‐induced cardiotoxicity (ADIC) becomes the second leading cause of death for tumor survivors after tumor recurrence and metastasis, and there may be great room for development in the future of traditional Chinese medicine (TCM). However, the theory of anticardiotoxicity of TCM has not yet formed a system. This study aimed to explore the material basis and the rule of TCM against ADIC based on network pharmacology and data mining. Methods. The targets of antineoplastic drugs with cardiotoxicity were obtained from the National Center for Biotechnology Information (NCBI) database, China national knowledge infrastructure (CNKI) database, and Swiss Target Prediction platform. Then, the cardiotoxicity‐related targets were derived from the Gene Cards, Disgenet, OMIM, and DrugBank databases, as well as the drug of current clinical guidelines. The targets both in these two sets were regarded as potential targets to alleviate ADIC. Then, candidate compounds and herbs were matched via Traditional Chinese Medicine Systems Pharmacology (TCMSP) platform. Cytoscape3.7.1 was used to set up the target‐compound‐herb network. Molecular docking between core targets and compounds was performed with AutodockVina1.1.2. The rules of herbs were summarized by analyzing their property, flavor, and channel tropism. Results. Twenty‐one potential targets, 332 candidate compounds, and 400 kinds of herbs were obtained. Five core targets including potassium voltage‐gated channel subfamily H member 2 (KCNH2), cyclin‐dependent kinase 1 (CDK1), matrix metalloproteinase 2 (MMP2), mitogen‐activated protein kinase1 (MAPK1), and tumor protein p53 (TP53) and 29 core compounds (beta‐sitosterol, quercetin, kaempferol, etc.) were collected. Five core herbs (Yanhusuo, Gouteng, Huangbai, Lianqiao, and Gancao) were identified. Also, the TCM against ADIC were mainly bitter and acrid in taste, warm in property, and distributed to the liver and lung meridians. Conclusion. TCM against ADIC has great potential. Our study provides a new method and ideas for clinical applications of integrated Chinese and western medicine in treating ADIC.

28 April 2021 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
WYWingyan Yun
Wingyan Yun
WDWenchao Dan
Wenchao Dan
JLJinlei Liu
Jinlei Liu
XGXinyuan Guo
Xinyuan Guo
MLMin Li
Min Li
QHQingyong He
Qingyong He
Although traditional Chinese medicine is effective and safe for the treatment of angiogenesis, the in vivo intervention mechanism is diverse, complex, and largely unknown. Therefore, we aimed to explore the active ingredients of traditional Chinese medicine and their mechanisms of action against angiogenesis. Data on angiogenesis-related targets were collected from GeneCards, Therapeutic Target Database, Online Mendelian Inheritance in Man, DrugBank, and DisGeNET. These were matched to related molecular compounds and ingredients in the traditional Chinese medicine system pharmacology platform. The data were integrated and based on the condition of degree > 1, and relevant literature, target-compound, compound-medicine, and target-compound-medicine networks were constructed using Cytoscape. Molecular docking was used to predict the predominant binding combination of core targets and components. We obtained 79 targets for angiogenesis; 41 targets were matched to 3839 compounds, of which 110 compounds were selected owing to their high correlation with angiogenesis. Fifty-five combinations in the network were obtained by molecular docking, among which PTGS2-astragalin (9.18kcal/mol), KDR-astragalin (7.94kcal/mol), PTGS2-quercetin (7.41kcal/mol), and PTGS2-myricetin (7.21kcal/mol) were top. These results indicated that the selected potential core compounds have good binding activity with the core targets. Eighty new combinations were obtained from the network, and the top combinations based on affinity were KDR-beta-carotene (10.13kcal/mol), MMP9-beta-sitosterol (8.04kcal/mol), MMP9-astragalin (7.82kcal/mol), and MMP9-diosgenin (7.51kcal/mol). The core targets included PTGS2, KDR, VEGFA, and MMP9. The essential components identified were astragalin, kaempferol, myricetin, quercetin, and β-sitosterol. The crucial Chinese medicines identified included Polygoni Cuspidati Rhizoma et Radix, Morus alba Root Bark, and Forsythiae Fructus. By systematically analysing the ingredients of traditional Chinese medicine and their targets, it is possible to determine their potential mechanisms of action against pathological angiogenesis. Our study provides a basis for further research and the development of new therapeutics for angiogenesis.

1 April 2021 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
SHShuaihang Hu
Shuaihang Hu
WDWenchao Dan
Wenchao Dan
JLJinlei Liu
Jinlei Liu
PHPeng Ha
Peng Ha
TZTong Zhou
Tong Zhou
WHWei Hou
Wei Hou
In this study, the role of traditional Chinese medicine (TCM) in relieving epidermal growth factor receptor-tyrosine kinase inhibitor- (EGFR-TKI-) associated diarrhea was discussed by network pharmacology and data mining. Prediction of drug targets by introducing the EGFR-TKI molecular structures into the SwissTargetPrediction platform and diarrhea-related targets in the DrugBank, GeneCards, DisGeNET, and OMIM databases were obtained. Compounds in the drug-disease target intersection were screened by absorption, distribution, metabolism, and excretion parameters and Lipinski’s rule in Traditional Chinese Medicine Systems Pharmacology. TCM-containing compounds were selected, and information on the property, taste, and meridian tropism of these TCMs was summarized and analyzed. A target-compound-TCM network diagram was constructed, and core targets, compounds, and TCMs were selected. The core targets and components were docked by AutoDock Vina (Version 1.1.2) to explore the target combinations of related compounds and evaluate the docking activity of related targets and compounds. Twenty-three potential therapeutic TCM targets for the treatment of EGFR-TKI-related diarrhea were obtained. There were 339 compounds acting on potential therapeutic targets, involving a total of 402 TCMs. The results of molecular docking showed good binding between the core targets and compounds, and the binding between the core targets and compounds was similar to that of the core target and the recommended drug loperamide. TCMs have multitarget characteristics and are present in a variety of compounds used for relieving EGFR-TKI-associated diarrhea. Antitumor activity and the efficacy of alleviating diarrhea are the pharmacological basis of combining TCMs with EGFR-TKI in the treatment of non-small-cell lung cancer. The core targets, compounds, and TCMs can provide data to support experimental and clinical studies on the relief of EGFR-TKI-associated diarrhea in the future.

25 April 2022 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
WDWenchao Dan
Wenchao Dan
CWCong Wu
Cong Wu
CXChunyan Xue
Chunyan Xue
JLJinlei Liu
Jinlei Liu
XGXinyuan Guo
Xinyuan Guo
YLYanjie Lian
Yanjie Lian
Objective. To explore the mechanism and principles of traditional Chinese medicine (TCM) in the management of radiation pneumonia. Methods. The targets of radiation pneumonia were obtained by screening the GeneCards, OMIM, TTD, DrugBank, and HERB databases, analyzing ADME parameters. In addition, compounds and Chinese herbs that can act on the targets were screened from the TCMSP database. The core target compounds for TCM were used to construct the target-compound, compound-traditional Chinese medicine, and target-compound-traditional Chinese medicine networks. These networks were further used to select the core targets, compounds, and TCM. The binding strength between the core targets and compounds was determined using AutoDock Vina. The trajectory for the molecular dynamics simulation was completed by Desmond version 2020. Results. A total of 55 active targets in radiation pneumonia were identified. Subsequently, 137 candidate compounds and 469 Chinese herbs were matched. Frequency statistics showed that the Chinese herbs that could interfere with radiation pneumonia were mainly bitter, spicy, and sweet, with both cold and warm properties. Moreover, they mainly belonged to liver and lung channels. The core targets included TNF, IL-6, TGF-β1, and TP53. The most important components were quercetin, resveratrol, and (-)-epigallocatechin-3-gallate. Moreover, the most significant traditional Chinese herbs were Perilla pueraria, ephedra, Lonicerae japonicae, and sea buckthorn. Furthermore, analysis of 222 sets of receptor-ligand docking results suggested that the compounds had good docking activity to their core targets. By combining the docking binding energy, we determined that the chemical compounds had strong binding energy to the targets. Conclusion. Using network pharmacology, we explored the potential mechanism of TCM in the treatment of radiation pneumonia. The general rules for application of TCM in the treatment of radiation pneumonia were summarized. This study provides baseline information for future research on the development of TCM for the management of radiation pneumonia.

1 June 2011
Verified
Journal Article
Closed access
WLWen Li
Wen Li
JLJin-Lei Liu
Jin-Lei Liu
LLLu-Yun Li
Lu-Yun Li
GLGuangxiu LU
Guangxiu LU
Mutation screening was performed in a pedigree of Glanzmann's thrombasthenia (GT) and prenatal diagnosis was performed. In this study, reverse transcription-PCR-sequencing and PCR-sequencing, as well as restriction fragment length polymorphism(RFLP) and A/T-cloned-sequencing, were used to screen the ITGA2B and ITGB3 mutation in a pedigree with Glanzmann's thrombasthenia in the RNA and DNA level. Prenatal diagnosis was performed for this pedigree. Deletion of 99 bps was found in the cDNA of the patient in the pedigree, leading to deletion of 33 codons (from codon 160 to 192). After genomic analysis, the patient was found to be a compound heterozygote of c.374C to G mutation and intron 4(IVS-4) + 5 G to C mutation. The two mutations were inherited from the parents. IVS-4 + 5 G to C mutation was a point mutation in the splice site, while c.374C to G mutation was out of the splice site. But both of them resulted in the same splice pattern in RNA. The two mutations were novel mutations which have not been reported in Human Gene Mutation Database (HGMD) and the mutation data base of Glanzmann's thrombasthenia. The results of ITGB3 gene screening is normal in the proband and his parents. Two novel mutation, c.374C to G and IVS-4 + 5 G to C were found in this study, which might be the cause of GT in the pedigree.

1 January 2019 in Journal of Diseases and Medicinal Plants
Verified
Journal Article
Open access
PDF file
XFXue Fang
Xue Fang
JLJinlei Liu
Jinlei Liu
LYLirui Yang
Lirui Yang
Xiang-Guo LiXiang-Guo Li
Xiang-Guo Li
Background: The main antibacterial component of Pulsatilla chinensis is anemonin, which has strong antibacterial effect, so it is studied. The Pulsatilla chinensis is one of the diseases that are difficult to solve in the growth of ginseng, but chemical control not only causes harm to the environment, but also has residues on ginseng itself. Pulsatilla is a good medicinal plant. It will have a certain effect on the prevention and treatment of ginseng disease, and it can do no residue, no harm to ginseng. Objective: This experiment can provide effective data support for the prevention and treatment of Pulsatilla chinensis. Method: In this experiment, Pulsatilla Chinensis was used as experimental materials to extract plant by reflux, ultrasonic extraction methods, the content of anemonin in each single factor experiment was determined by HPLC. According to the content, the response surface analysis method was used to find the best extraction process, and the mycelium growth rate method was further used to determine the antifungal effect of Alternaria panax. Results: The EC50 value of P. Chinensis extract to A. panax was methanol extract < acetone extract < ethanol extract in order from small to large; The optimum extraction conditions of anemonin, the effective component of P. Chinensis methanol extract, were as follows: methanol volume fraction 87%, extraction time 2 h, solid-liquid ratio 20 (V: m), the optimum extraction amount was 3.760 μg·g-1.